ABSTRACT: Ovariectomy induces deterioration of the trabecular structure in the femoral neck of ewes, as depicted by MR microscopic imaging. This structural deterioration is prevented by salmon calcitonin treatment.
INTRODUCTION

C
URRENT ASSESSMENT OF osteoporosis, a disease characterized by low bone mass and bone architectural deterioration, consequently increasing the risk of atraumatic fractures, (1) is based on bone densitometry techniques such as QCT and DXA. Although BMD is a widely used method for assessing fracture risk and therapeutic efficacy, it does not always predict the risk of individual fractures or of bone strength, nor does it completely assess the impact of a particular intervention. (2) (3) (4) (5) (6) (7) (8) Changes in BMD in the spine and hip during antiresorptive treatment are correlated with reduction of nonvertebral fractures.
(9) However, the relation between changes in BMD and reduction of vertebral fractures during therapy is less clear. Clinical trials have shown that the correlation of BMD increases with vertebral fracture risk reduction has proved less consistent than correlation of BMD decreases with greater vertebral fracture risk Dr Jiang received a grant from Novartis. Dr Azria is an employee of Novartis. Dr Genant is a member of the Novartis Advisory Board. All other authors have no conflict of interest. 1 in the untreated. In the Prevent Recurrence of Osteoporotic Fractures (PROOF) study, calcitonin reduced vertebral fracture risk 33% over 5 years, although the increase in spinal BMD was <1.5%. BMD change was statistically significant at years 1 and 2. By the end of the trial, it was 0.6% higher than the placebo group.
(10) The Fracture Intervention Trial (FIT) showed that T scores of high-risk women treated with alendronate for 2.9 years rose at the spine, hip, and forearm by 0.5, 0.2, and 0.1 SD, predicting fracture reductions of 25%, 10%, and 5%, respectively, whereas fracture decreases at these sites were 55%, 51%, and 48% greater than seen in controls.
(11) A recent reanalysis of the FIT results determined that BMD change from baseline accounted for only 16% of the reduction in vertebral fractures in treated women.
(12) The Multiple Outcomes of Raloxifene Evaluation (MORE) trial concluded that only 4% of the 30% decrease in vertebral fractures they observed in raloxifene-treated women was attributable to the 2.6% increase in spinal BMD.
(13) Antiresorptive therapy may help maintain trabecular microarchitecture. Thus, the quantitative analysis of trabecular structure may help elucidate the relationships between structural parameters and bone strength. (14) (15) (16) MRI, a complex technology, can clearly delineate trabecular bone because bone mineral lacks free protons and generates no MR signal, whereas adjacent soft tissue and marrow contain abundant free protons and give a strong signal. Using small, highly efficient coils in high-field scanners, MRI can be performed at resolutions sufficient to discriminate individual bone trabeculae. (14) High-resolution MR images that resolve trabecular bone structure can be obtained in vitro at high magnetic field strengths. (14, (17) (18) (19) We have shown that, with appropriate sequences, it is possible to image trabecular bone in rats in vivo and in vitro. (20, 21) In ovariectomized (OVX) rats, MRI shows differences in trabecular bone that are not detected by DXA, which is projectional rather than tomographic, and can not completely eliminate the effects of cortical bone. (20, 21) MRI has several advantages in the assessment of bone structure: it gives 3D structure in arbitrary orientations; it is nondestructive, allowing multiple tests on the same sample; and it is noninvasive and nonionizing.
Calcitonin, an osteoclast inhibitor, may also enhance osteoblastic bone formation. (22, 23) It inhibits OVX-induced increase of bone resorption in rats. (24, 25) We have shown that salmon calcitonin (sCT) preserved BMD measured by DXA and bone strength in trabecular bone of the femoral neck in sheep treated with sCT. (26) In postmenopausal women injected with sCT, the initial sCT study showed clinical efficacy. (27) It prevents trabecular bone loss when given immediately after menopause. (28) Parenterally injected sCT has beneficial effects on bone mass throughout the skeleton, including the proximal femur, at least in patients with established osteoporotic fractures. (29) In early postmenopausal women, sCT, given by nasal spray, inhibits trabecular bone loss without affecting cortical bone loss, (28) indicating that trabecular bone is probably more sensitive to the effect of calcitonin. (30) In a multicenter, randomized, double-blind, placebo-controlled clinical trial, calcitonin has been shown to prevent incident vertebral fracture in osteoporotic postmenopausal women, although its effect on BMD was only modest.
(10) Cross-sectional data have even suggested a protective effect on hip fracture incidence. (31) Our hypothesis is that MRI microscopy will provide additional insight into the trabecular bone microstructure and therefore bone quality of an osteoporotic model in ewes and the response of this model to calcitonin therapy. The specific aims of this study were to evaluate by MRI the trabecular bone microstructure in an OVX-induced osteoporosis model in ewes and to evaluate the effects of treatment on the model with sCT. From these animals, we have reported previously a nonsignificant loss in BMD in the femur after OVX and a significant decrease in biomechanical competence in the trabecular bone cylinder specimen of the femoral neck. Treatment with sCT, at both 50 and 100 IU, resulted in significantly greater compressive stress of the trabecular bone cylinder compared with OVX. (26) 
MATERIALS AND METHODS
Animals
Twenty-eight middle-aged (5-8 years old) ewes with a mean body weight of 62 kg were randomly allocated to four groups with seven animals in each group and studied double-blindly: sham OVX injected with a vehicle (Sham), OVX injected with a vehicle (OVX), OVX injected with sCT at 50 IU (OVX + sCT 50), and OVX injected with sCT at 100 IU (OVX + sCT 100). All animals were injected subcutaneously three times per week. Three times per week instead of daily injections were chosen because at the time of the study there was interest in intermittent treatment. They were housed on straw litter, had free access to an automatic drinking trough, and received a daily diet based on hay and a concentrated supplement for each animal of 4 g calcium, 3 g phosphate, 1 g magnesium, 2 g potassium, 1 g sodium, and 300 IU vitamin D 3 . All animals were entered in the study within a 4-day period to exclude potential seasonal variations. Operations were performed under fluothame anesthesia. The animals were killed 6 months after operation. The left femoral neck and head were excised, and muscles and fat were removed. The Institutional Committee of Animal Research approved the research protocol. (26) MR imaging MR images of the femoral neck and head were obtained in axial, coronal, and sagittal planes, using a spin echo multislice pulse sequence with TR 1 s, TE 1.8 ms, in-plane resolution 78 , and slice thickness 1 mm on a Varian Unity 400 NMR instrument at 9.4 T. For image analysis, MR images were transferred to a Sun/SPARC 20 Workstation (Sun Microsystems, Mountain View, CA, USA). The images were processed with in-house semiautomated image processing software tools developed at UCSF (32) (33) (34) using AVS (Advanced Visual Systems, Waltham, MA, USA) software interfaces on the workstation.
Imaging processing
The central five slices of the femoral neck were selected for image analysis. The femoral neck was chosen because of its relevance to human osteoporotic hip fracture. An analysis region of interest (ROI) was positioned in the trabecular area of the femoral neck, carefully avoiding the cortical bone and physis, or ossified remnant of the fused growth plate.
An ''internal calibration'' procedure as a means of standardizing the analysis of images obtained at different times and in different samples, which was described in detail previously, (32) (33) (34) was used to adjust the threshold value applied to each scan for overall differences in gray-level brightness and contrast. Briefly, the segmentation threshold for each image was determined from the average gray-level values within four ''calibration ROIs,'' that is, two ROIs in cortical bone, yielding low gray-level values, and two ROIs in bone marrow, yielding high gray-level values, on all five contiguous midslices, and the mean gray-level value in each ROI was measured. The segmentation threshold for trabecular bone must separate image pixels representing marrow from those representing bone trabeculae, and therefore, lies somewhere between the high (bright) gray-level values of bone marrow and the low (dark) gray-level values of cortical bone. A single threshold (Th) value was calculated for all five image slices, Th ‫ס‬ Co + ␦(1 − Co/Ma), where Co and Ma denote the mean gray value of cortical bone and bone marrow over the five slices, respectively, and ␦ is an operator-defined empirical constant. The factor (1 − Co/ Ma) normalizes the dynamic range of the grayscale in each image. Averaging over all five slices, values greater than the threshold were set to non-bone, and the remaining pixels were set to bone, generating a binary image.
The run-length method (35) was used to calculate the trabecular structure from the binary ROI. Morphological measurements, extrapolated from standard techniques of stereology, were used to derive trabecular bone volume fraction (BV/TV), thickness (Tb.Th), and separation (Tb.Sp). Measurements of trabecular connectivity, including number of trabecular nodes, number of free ends, number of branches, and mean length of the branches were obtained from the skeletonized trabecular network generated by using thinning algorithms. (36) All skeletons possessed the typical properties such as connectedness and one-pixel thickness.
The analysis was performed on MR images of all three axial, coronal, and sagittal planes, and their results were averaged for each specimen. The operators were blinded to treatment for MR images acquisition and analysis.
Statistical analysis
Comparisons among groups were performed using the ANOVA test. In the multiple comparison procedure, p < 0.0125 was considered significant after Bonferroni adjustment. Relationships between the biomechanical properties, morphometrical parameters, and BMD were assessed using linear regression analyses. The relationship between a combination of more than one parameter, namely trabecular structural parameters and bone mineral measurements, with the biomechanical properties was studied using multivariate regression analysis. In the multivariate regression analysis, all trabecular structural parameters and bone mineral measurements were added into the model as predictive variables, whereas compressive stress was the outcome variable. The insignificant variables were excluded.
RESULTS
As shown in Table 1 and Fig. 1 , OVX induced significant changes in all trabecular microstructural parameters in the femoral neck except trabecular thickness. Compared with OVX, treatment of sCT at 100 IU significantly improved all the trabecular microstructural parameters in the femoral neck except trabecular bone volume fraction and trabecular thickness, whereas at 50 IU, sCT significantly increased the trabecular number and the mean length of the trabecular branches.
Trabecular bone volume fraction explained 74% of the variance in compressive stress (Fig. 2) . Combining all structural parameters significantly improved the predictive ability to 84%, and adding BMD further improved the proportion explained by the model to 92%. Trabecular bone volume fraction moderately correlated with biomechanical parameters, whereas all other trabecular microstructural parameters modestly related with the results of the biomechanical testing (Table 2) .
No significant differences between groups were found in serum calcium, phosphate, alkaline phosphatase, calcitonin, and osteocalcin (data not shown). 
DISCUSSION
In this study, we quantified OVX induced loss of the trabecular microstructure by 3D MR microscopic imaging of the femoral neck of the ewes. These OVX-induced changes in trabecular microstructure were prevented by sCT treatment. This is the first report of MRI-derived Tb microarchitectural deterioration in the femoral neck induced by OVX and protective effects of sCT on the microstructure in the ewes.
Preservation of the trabecular microstructure in the femoral neck of the estrogen-deprived ewes by sCT is not unexpected, in view of the clinical studies of sCT in osteoporosis.
(10, 27, 28, 30, 37) Our data are also in agreement with other preclinical observations. In addition to its inhibitory effects on osteoclastic bone resorption, calcitonin may enhance osteoblastic bone formation. (22, 23) Studies in OVX rats using traditional 2D bone histomorphometry have shown that subcutaneous administration of calcitonin is associated with a partial inhibition of the OVX-induced increase in bone resorption, without detriment effects on osteoid volume or mineralization lag time. (24, 25) In young adult rats, 3 U/kg subcutaneously for 40 days did not show detrimental effects on femoral torsional mechanical properties, (38) whereas adult beagles treated with calcitonin at 8 mg/kg/day for one-half of a year had a significant decrease in the whole lumber vertebra (L 2 ) strength. (39) The latter discrepant result remains enigmatic and unexplained. In the adult OVX ewe model, we have previously reported the positive effect of long-term intermittent administration of sCT on femoral cortical and trabecular bone strength. (26) To this end, torsional and compressive tests as well as resonant frequency analysis were performed. After treatment with sCT, compressive stress was found to be preserved in the trabecular cylinder core of the femoral neck. Because the relation between the mineral and the organic matrix may contribute to bone biomechanical properties, crystallographic parameters and crystal size and/or perfection were measured by powder X-ray diffractometry to assess the chemical stability and the mechanical strength of the bone mineral. We found no changes in diffraction pattern and no effect of OVX or sCT treatment on crystal size or perfection parameters. (26) These results were in line with prior histomorphometric reports, showing no deleterious effect of subcutaneously injected calcitonin on bone mineralization in humans. (40, 41) They may point to a difference between sCT and other inhibitors of bone resorption, such as bisphosphonates, which bind strongly to hydroxyapatite crystals and potentially may inhibit crystal formation and dissolution. (42) The changes in the femoral neck trabecular microstructure after OVX and sCT treatment are more sensitively assessed than the changes in the bone mineral measurements using both DXA and dual energy quantitative CT (DEQCT). (26) In a human study, no significant difference was found in pQCT trabecular BMD at the distal radius in vivo between premenopausal and postmenopausal women, but the number of trabecular perforations significantly increased in postmenopausal compared with premenopausal women. These results indicate that increased disconnectivity may occur without a significant reduction of BMD and that trabecular bone connectivity is more sensitive than BMD in the detection of the early changes of postmenopausal osteoporosis. (43) The findings in this study can be explained by several arguments. MR microscopic imaging has very high resolution, allowing pinpoint evaluation of the trabecular structure of the secondary spongiosa of the femoral neck. The sensitivity of DEQCT could be compromised because of relatively large field of view (FOV) and small specimen, which would result in partial volume average of both trabecular and cortical bone at the endocortical junction, masking of purely trabecular bone changes. In addition, the bone in the epiphysis, physis, and primary spongiosa usually changes little in response to estrogen deprivation, (19) and these regions might be included in the measurement ROI because of partial volume average in the DEQCT examination. Similarly, the DXA examination of the cylinder core might also include the epiphysis, physis, and primary spongiosa. Finally, Table 2 shows that, among correlation coefficients between trabecular microstructural parameters and BMD of both DEQCT and DXA examination, bone volume fraction has highest correlation. After Bonferroni correction in the multiple comparison procedure, the increase of bone volume fraction in the sCT-treated animals is no longer statistically significant. The discrepancy of lack of significant changes in bone volume fraction and in BMD but significant changes in biomechanical properties in the femoral neck trabecular bone after sCT treatment in this study is in agreement with modest change in BMD but significant reduction in vertebral fracture rate observed in clinical trial. (10) Our finding that a combination of microstructural parameters with bone mineral measurements provided the best prediction of bone strength is in line with our earlier work predicting the mechanical properties of trabecular bone cubes from human vertebral bodies. (33) Previous studies have reported modest correlations between trabecular structural parameters as assessed by CT and BMD of the lumbar vertebrae. (44) Similarly, modest correlations have been reported in a study of MRI-assessed trabecular structure and CT-determined BMD. (45) Our study, along with previous other reports, (33, 44, (46) (47) (48) support the concept that structural analysis provides an additional tool to analyze bone quality of trabecular bone. Further studies are warranted to investigate the microstructure and biomechanical properties of the cortical bone after antiresorptive therapy.
In summary, OVX induces a deterioration of the trabecular microstructure in the femoral neck of the adult ewe. 
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